Use of an oxfendazole pulse release bolus in the control of parasitic gastroenteritis and parasitic bronchitis in first-season grazing calves

Antigen selection for future anti-Trichuris vaccines: a comparison of cytokine and antibody responses to larval and adult antigen in a primary infection

Trichuriasis, caused by the whipworm Trichuris trichiura, is endemic in tropical and subtropical areas, affecting approximately 1 billion people. Child anthelminthic treatment programmes are being implemented but repeated treatments are costly, may prevent the development of acquired immunity and can lead to the development of drug resistant parasites. Thus, the development of a vaccine which would lead to the acquisition of immunity at an earlier age and reduce community faecal egg output would be beneficial. Development of subunit vaccines requires the identification of protective antigens and their formulation in a suitable adjuvant. Trichuris muris is an antigenically similar laboratory model for T. trichiura. Subcutaneous vaccination with adult excretory-secretory products (ES) protects susceptible mouse strains from T. muris. Larval stages may contain novel and more relevant antigens which when incorporated in a vaccine induce worm expulsion earlier in infection than the adult worm products. This study finds negligible difference in the cellular and humoral immune response to T. muris adult and third stage larva(e) (L3) ES during a primary T. muris infection, but identifies high molecular weight proteins in both adult and L3 ES as potential vaccine candidates.

Immunomodulatory effect of various anti-parasitics: a review

This paper reviews the immunomodulatory effects (immunosuppression or immunoactivation) of various anthelmintics including levamisole, fenvalerate, dieldrin, carbofuran, aminocarb, thiabendazole, fenbendazole, oxfendazole and ivermectin. The induced modulation of immune function may occur via direct and/or indirect mechanisms. The immunomodulatory effects of these anti-parasitics have been studied in a variety of bacterial (e.g. brucellosis, salmonellosis, paratuberculosis, mastitis), viral (e.g. infectious bovine rhinotracheitis, Herpes, foot and mouth disease), parasitic (e.g. onchocerciasis, coccidiosis, ascariasis, schistosomiasis) and neoplastic diseases. Some antiparasitics have also been used to boost immunity in a number of human diseases including leprosy, Hodgkin's disease, rheumatoid arthritis, and in adjuvanted therapy of colorectal cancer. The ability to stimulate the immune response of animals offers a new means of disease intervention. Future research on immunomodulatory effects of anti-parasitics, for humans and domestic farm animals, will provide additional methods of treating immunosuppressed subjects. The immunopotentiating or immunosuppressing activity of anti-parasitics will dictate whether co-administration of vaccines and anthelmintics or administration of vaccines during the window of immunoactivation is justified or not.

Seroprevalence of Dictyocaulus viviparus in first grazing season calves in Sweden

A serological survey was carried out to determine the prevalence and geographical distribution of Dictyocaulus viviparus in calves after their first grazing season in Sweden. A total of 754 animals from 76 randomly selected herds in seven geographical regions were examined between September 24 and December 19, 2001. To get an indication about the geographical distribution of the infection 41 herds with beef-suckler calves were investigated. On each farm, blood was collected from 8 to 10 animals after an average of 26 +/- 24 days post-housing to determine specific IgG1 levels against a possible lungworm sperm antigen that is highly specific against patent infections of D. viviparus. We also investigated the seroprevalence of lungworm infection in relation to cattle management. In one region additional samples were analysed from 35 herds either with: (a) beef-suckling calves that were dewormed at housing, (b) untreated organically raised dairy calves, and finally from conventionally raised dairy calves either, (c) with or, (d) without a prophylactic anthelmintic treatment programme against gastrointestinal parasites on pasture. A questionnaire was used to obtain information about herd size and management, including measures to control nematode parasites on the farm. A total of 86 (11.8%) out of 754 animals had antibodies against D. viviparus, and at least one infected individual was detected in 30 (39.5%) of the 76 herds examined. Lungworm infected animals were found throughout the country and there was no significant differences between regions, although in southern and southwestern Sweden 70.0% of the herds were infected. Furthermore, there were no major differences in the seroprevalence in relation to management. Between 40.0 and 44.4% of the herds were infected irrespective of management, with the exception of calves from organic herds where no seropositive samples were found (0%). This result is in contrast to previous findings of lungworms in Sweden, and indicates that the parasite status on organic farms is diverse.

Control of gastrointestinal nematodes in first season grazing calves by two strategic treatments with eprinomectin

A study was carried out to evaluate the effects of strategic early-season treatments with eprinomectin on first-season grazing calves exposed to strongyle infections on a naturally contaminated pasture. Two groups of first grazing season (FGS) calves were turned out in mid-May on two plots that were similar with respect to size and herbage infectivity. They grazed separately until housing at the end of October. One of these groups was given eprinomectin pour-on at turnout and 8 weeks later, while the other group served as untreated controls. The results showed that the treatments reduced gastrointestinal strongyle infections throughout the season as evidenced by lower faecal egg counts and serum pepsinogen levels compared with the controls. Furthermore, the results of herbage larval counts and postmortem worm counts in tracer animals demonstrated that the treatment had reduced herbage infectivity on the 'treated' plot. Finally, the chemoprophylactically treated calves had a better weight gain over the duration of the study than the untreated controls.

The efficacy of two isolates of the nematode-trapping fungus Duddingtonia flagrans against Dictyocaulus viviparus larvae in faeces

A series of experiments was carried out to examine the effects of two different isolates of the nematode-trapping fungus Duddingtonia flagrans to reduce the number of free-living larvae of the bovine lungworm, Dictyocaulus viviparus. A laboratory dose-titration assay showed that isolates CI3 and Troll A of D. flagrans significantly reduced (P < 0.05 to P < 0.001) the number of infective D. viviparus larvae in cultures at dose-levels of 6250 and 12,500 chlamydospores/g of faeces. The larval reduction capacity was significantly higher for Troll A compared to CI3 when lungworm larvae were mixed in faecal cultures with eggs of Cooperia oncophora or Ostertagia ostertagi and treated with 6250 chlamydospores/g of faeces. Both fungal isolates showed a stronger effect on gastrointestinal larvae than on lungworm larvae. Two plot trials conducted in 1996 and 1997 involved deposition of artificial faecal pats containing free-living stages of D. viviparus and C. oncophora on grass plots. Herbage around the pats was collected at regular intervals and infective larvae recovered, counted and identified. These experiments showed that both D. flagrans isolates reduced the number of gastrointestinal as well as lungworm larvae in faecal pats. During both plot trials, the transmission of C. oncophora larvae, but not D. viviparus, from faecal pats to the surrounding herbage was clearly affected by climatic conditions. After collection of faecal pats from the grass plots one month after deposition, the wet and dry weight of pats as well as organic matter content were determined. No differences were found between the fungus-treated and non-treated control pats. This indicated that the rate of degradation of faeces was not affected by the addition of the fungus.

The determination at housing of exposure to gastrointestinal nematode infections in first-grazing season calves

Various parameter estimates were assessed at housing in calves that had been exposed to gastrointestinal nematodes during a first grazing season. The analysis involved 41 groups of first grazing season (FGS) calves on 15 different farms in Belgium and comprised groups that had received chemoprophylactic treatment and untreated controls. Serum pepsinogen levels gave the clearest division between chemoprophylactic-treated calf groups (all were <2.6 U tyr), and untreated calf groups in which sub-clinical (range: 2.0-4.1 U tyr) and clinical infections (range 3.7-6.3 U tyr) occurred. There was also a tight relationship between individual pepsinogen values and adult Ostertagia burdens obtained at slaughter. In chemoprophylactic-treated groups there was a significant negative relationship between mean serum pepsinogen levels at housing and the proportion of the grazing season covered by different chemoprophylactic systems. Although only limited data on crude adult Ostertagia antigen ELISA were available, a good relationship between optical densities and estimated exposure was also found. The parasitological parameters, faecal egg counts and pasture Ostertagia larval counts at housing, and weight gain per day, gave less clear divisions among the three categories (chemoprophylaxis, sub-clinical and clinical). Distinguishing how much exposure a calf group has experienced during a first grazing season could help in designing more appropriate control measures for the FGS calves in the next year, assuring good protection and at the same time allowing sufficient exposure for the development of acquired immunity to Ostertagia, and for this serum pepsinogen is recommended.

Field evaluation of a topical doramectin formulation for the chemoprophylaxis of parasitic bronchitis in calves

A study was conducted to evaluate the efficacy of two topical treatments with doramectin on the season-long control of lungworm and gastrointestinal infections in first grazing season (FGS) calves. At the start of the study, 20 FGS calves were randomly allocated into two treatment groups of 10 animals each. Calves in the D-group were treated with doramectin pour-on on days 0 and 56, at a dosage of 500 microg kg(-1) BW: calves in the C-group were designated as controls. A permanent pasture was divided in two blocks and these were randomly allocated to the treatment groups. Throughout the study, tracers (n = 32) were grazed on each paddock at 3-week intervals. Clinical signs of parasitic bronchitis (PB) were observed in the C-group in July and this necessitated two salvage treatments with levamisole. From day 28, post-turnout lungworm larvae were recovered from faeces of the C-calves until housing. No signs of PB were observed in the D-group during the entire grazing season. Shedding of lungworm larvae in the principals of the D-group did not occur until 112 days post-turnout. From the data obtained from the tracer calves. it appeared that larvae had overwintered on both pastures. On the C-pasture, the number of lungworms recovered from the tracer calves gradually increased to a peak in September, whereas on the D-pasture, the increase was observed only at the end of the pasture season. Both strongyle faecal egg counts and pepsinogen levels were relatively low in both groups throughout the present study. At the end of the grazing period (day 161). the principals were housed and treated with oxfendazole. During the housing period, all principal animals (D- and C-groups) and a third group of four helminth free animals (N-group) received a challenge infection with Dictyocaulus viviparus. It appeared that the different exposure to the parasite during the grazing season resulted in different establishment rates, i.e.. group C < group D < group N. The present results show that overwintering of lungworm larvae occurs in Belgium and that in such conditions, doramectin pour-on given at turnout and at 8 weeks controls PB in calves during the first grazing season.

Gastrointestinal nematode infections of first-grazing season calves in Western Europe: general patterns and the effect of chemoprophylaxis

Research on the prevention of gastrointestinal nematode infections of cattle has mainly concentrated on comparing a specific chemoprophylactic treatment system to an untreated control group on a particular farm. Here, the results from analysis of 85 studies involving over 2000 first grazing season (FGS) calves put onto pasture for at least 4 months from late spring/early summer over a 26-year period in 13 countries in Western Europe are presented. Both control and chemoprophylactic treated FGS calf groups were considered. All chemoprophylactic systems (slow- and pulse-release boli, strategic treatments) were given early in the grazing season. Two general infection levels emerged--'sub-clinical' (32 studies) and 'clinical' (53 studies). The 'sub-clinical' infections were characterised by no clinical symptoms of parasitic gastroenteritis (PGE) being observed in the control groups. Mean faecal egg counts in the 'clinical' control groups were significantly higher than those for 'sub-clinical' control groups for almost the entire season with overall peaks of 275 and 100 EPG respectively. Maximum pasture larval counts were also significantly higher in the 'clinical' control groups with 44% of 'clinical' pastures > 10,000 L3 kg(-1) dry herbage by the end of the FGS, compared to only 15% of 'sub-clinical' pastures. There was a significant positive relationship between log transformed worm burdens from tracers put onto pastures for 2 weeks and the corresponding pasture larval count. No evidence of density dependence in tracer worm burden was observed. Weight gains in the 'clinical' control groups (375 g/day) were significantly lower than those of the 'sub-clinical' control groups (530 g/day). No symptoms of PGE were observed in any of the chemoprophylactic treated groups, but in those studies with an outbreak of PGE in the control group, the treated groups had significantly higher faecal egg and pasture larval counts than treated groups in 'sub-clinical' studies. The overall weight gain in chemoprophylactic treated calves in 'clinical' studies (600 g/day) was significantly lower than the chemoprophylactic treated calves in 'sub-clinical' studies (690 g/day), and was not significantly different from the weight gain of control calves in 'sub-clinical' studies. These results indicate that on heavily infected pastures, chemoprophylaxis will prevent PGE, but calves will still suffer production losses.

Control by management

It is currently possible to reduce significantly the number of anthelmintic treatments required by grazing ruminants by employing some relatively simple management procedures, enlightened by knowledge of the epidemiology of the parasites in the climatic region and production system in question. Some examples of these procedures, such as the Michel dose and move system for nematode control in cattle, strategic treatments at times of low larval availability for sheep and alternate grazing of sheep and cattle will be considered. While such procedures can have a major impact on frequency of anthelmintic treatment, they rarely have a commensurate effect on reducing selection for anthelmintic-resistant worms. Only in control systems that avoid the use of anthelmintics altogether is there any certainty of avoiding selection for resistance. The nearest approaches to this ideal goal are some alternate grazing schemes and rotational grazing systems currently being tested in tropical environments. Even if these anthelmintic-free production systems are successful, the worms are still being selected for attributes that may ultimately render these control procedures ineffective. Examples of this are the propensity for alternate grazing systems to select for reduced host specificity, or increased numbers of parasite species able to infect both host species. Similarly, rotational grazing systems could be subverted by selection for enhanced larval survival or faster development from egg to infective larva. Nevertheless, it is hoped that selection for such fundamental changes as those presumably required to affect survival, development or host specificity will be slower than selection for anthelmintic resistance.

Gastrointestinal nematode infections of first-season grazing calves in Belgium: general patterns and the effect of chemoprophylaxis

Comparative analyses of the patterns of gastrointestinal nematode infections of first-grazing season cattle in Belgium are presented. The analysis involves 17 studies covering a 10 year period on 13 different farms in Flanders, Belgium. In all studies the calves were divided into an untreated control group, and one or two groups treated with chemoprophylactic systems. Two general infection levels emerged-'sub-clinical' (14 studies) and 'clinical' (three studies). The 'sub-clinical' infections were characterised by no clinical signs of parasitic gastroenteritis in the untreated control groups. Mean faecal egg counts remained low (less than 200), maximum pepsinogen levels only reached about 3500 mU tyrosine, and very small reductions in overall daily weight gain were observed compared with calves given chemoprophylaxis (less than 40 g day-1). Based on these results, on these 'sub-clinical' farms, chemoprophylaxis may not have been needed. In contrast, multiple salvage treatments of the control calf groups were required in the 'clinical' infections. Even with these salvage treatments mean faecal egg counts were high (more than 300), maximum pepsinogen levels were over 5500 mU tyrosine and there was a very large reduction in overall daily weight gain (more than 300 g day-1). However, it was not possible to predict either at turnout, or during the first month afterwards whether an infection on a particular farm would develop into a 'clinical' infestation. With the present data this prediction was possible from 8 weeks (Day 56) onwards, based on faecal egg counts and pasture larval contamination. It was also possible to predict using serum pepsinogen levels on Day 84. Therefore, one possible strategy for the effective control of gastrointestinal nematode infections of calves in temperate regions would be to evaluate faecal egg counts 2 months after turnout, and then only start treatment (i.e. metaphylaxis) if required.

Prophylaxis of bovine trichostrongylidosis and dictyocaulosis in the alpine region: comparison of an early and late administration of the oxfendazole pulse release bolus to first year grazing calves

The effect of the oxfendazole pulse release bolus (OPRB) administered at turnout, in May, or in mid-July on the development of infections with gastrointestinal nematodes and lungworms in first year grazing calves was investigated with three groups of nine animals, all grazing the same pastures in the Swiss midland region. In the calves of Group A (OPRB on 21 May) less than 20 eggs per gram of faeces (e.p.g.) and less than three Dictyocaulus larvae per 10 g (1.p.10 g) of faeces were shed for a period of 126 and 140 days respectively. Towards the end of the grazing period calves of this group excreted significantly higher levels of lungworm larvae (P < 0.05) compared with the other groups. Prior to OPRB administration on 14 July, the calves of Group B developed subclinical infections with trichostrongyles and lungworms which were similar to the untreated control Group C. By 4 weeks after bolus-administration the excretion of trichostrongylid eggs and lungworm larvae declined to levels below 20 e.p.g. and six l.p.10 g respectively. Serum pepsinogen values of the calves of Groups A and B were significantly lower (P < 0.05) compared with the control animals on days 84 and 98 after turnout and reflected mainly subclinical infections. With the exception of one Group A calf developing clinical parasitic gastroenteritis (p.g.e.) at the end of the season, clinical disease was not observed in the treated calves, while seven out of nine control animals grazing on the same pastures exhibited clinical p.g.e. with mean serum pepsinogen values exceeding 4400 mU tyrosine. Calves of Groups A and B gained significantly more weight (P < 0.01) compared with Group C (+36 kg and +41 kg respectively); differences between Groups A and B were not significant. The results indicate that in mixed grazing systems of treated and untreated calves, which are often found in the alpine region, administration of the OPRB in May or July provided good results with respect to performance of the calves. However, late administration of the OPRB has the additional advantage of coverage of the period of higher infection risk with trichostrongyles and lungworms in the late season until stabling, and should therefore be recommended.

The development of protective immunity against gastrointestinal nematode and lungworm infections after use of an ivermectin bolus in first-year grazing calves

Interactions between treatment with an ivermectin bolus at turnout and immunity to bovine parasitic gastroenteritis and bronchitis were examined. Immunity related parameters, i.e. development of clinical disease, parasite development and stimulation of parasite specific antibodies were examined for two grazing seasons and compared with untreated second season cattle (immune control) and untreated parasite naive cattle (nonimmune control). With respect to gastrointestinal nematodes, clinical condition, body weight development, faecal egg counts and pepsinogen concentrations of the bolus treated animals were not significantly different from the respective values of untreated immune cattle, showing a considerable degree of resistance in both groups compared to the parasite naive cattle. With respect to lungworms, untreated immune cattle were protected against clinical disease, but two of eight animals shed larvae again. Bolus treated animals transiently showed mild clinical symptoms and six of seven animals shed low numbers of larvae again, whereas all parasite naive cattle shed high numbers of lungworm larvae and showed signs of disease during the whole grazing season. In spite of the effective treatment with an ivermectin bolus during the first year a considerable resistance to gastrointestinal nematode and lungworm infection was present in the second grazing season.

Development of immunity to lungworm in vaccinated calves treated with an ivermectin sustained release bolus or an oxfendazole pulse release bolus at turnout

The ivermectin sustained release bolus (IVSRB), when used at turnout as recommended, will provide season-long control of parasitic bronchitis, thus obviating the need for use of a lungworm vaccine. However, some concerns have been expressed that calves treated with an IVSRB will receive so little exposure to Dictyocaulus viviparus that it will compromise their immunity in subsequent grazing seasons, which would be of particular importance in dairy herds. Although there is evidence that IVSRB-treated calves can develop immunity to D. viviparus when exposed to pasture infection, it was considered worthwhile to evaluate the compatibility of the IVSRB and lungworm vaccination to allow veterinary surgeons the option of using these products concurrently when they have particular concerns about the long term immune status of replacement dairy heifers. Thirty-two dairy replacement heifers were vaccinated with two doses of lungworm vaccine and, at turnout, half the calves received an IVSRB and the remainder an oxfendazole pulse release bolus (OPRB). At the end of the grazing season four replicate bolus treated pairs and four parasite-naive calves were challenged with 1000 D. viviparus infective larvae. At slaughter there was a 95% and 93% reduction in D. viviparus burdens in the IVSRB and OPRB treated calves respectively, compared with the unvaccinated, untreated controls. These results indicate that where it is considered necessary to use lungworm vaccination in addition to an IVSRB or an OPRB, the compatibility of these products with lungworm vaccine will allow development of a protective level of immunity to D. viviparus.

Efficacy of a spring strategic fenbendazole treatment program to reduce numbers of Ostertagia ostertagi inhibited larvae in beef stocker cattle

Efficacy of a spring strategic treatment program with fenbendazole (FBZ) to reduce the accumulation of Ostertagia ostertagi inhibited early fourth-stage larvae (EL4) was investigated in two groups of crossbred beef heifers which were 7-9 months of age and ranged in weight from 155 to 223 kg. The cattle were allocated to groups and treated on 27 April (Day 0). Group 1 calves served as nontreated controls. Group 2 calves were treated with FBZ 10% drench suspension at 5 mg kg-1 on Day 0 and with 6-day courses of FBZ free-choice mineral (to provide 5 mg kg-1 per animal) on Days 28 and 56. Each group grazed on a separate 4.9 ha pasture for 105 days to 10 August. On 10 August the cattle were taken off pasture and each original group was re-allocated to subgroups of three cattle which were treated orally with FBZ (5 mg kg-1), oxfenbendazole (OXF, 4.5 mg kg-1) or left nontreated (CONT). The cattle were necropsied on Days 120 and 121. Mean actual and cumulative fecal egg counts indicated near total suppression of egg output in the strategically treated group (high of 5.2 eggs g-1 feces (EPG) on Day 28). Egg counts of the nontreated group remained above 100 or 200 EPG to Day 63 and then decreased to less than 100. Ostertagia was the predominant genus, followed by Cooperia on most sampling dates. The largest O. ostertagi worm burdens were recovered from the CONT-CONT subgroup; numbers of EL4 ranged from 18,922 to 51,137. Reduction in numbers of EL4 in original controls, treated with FBZ or OXF in August, were low, being 60.2% and 74.3%, respectively. The numbers of O. ostertagi recovered from subgroups originally treated strategically with FBZ were generally lower than in original controls. The largest reduction in O. ostertagi numbers was in the FBZ-CONT subgroup, which was not treated in August. Percent reduction values for O. ostertagi adults, developing L4 (DL4) and EL4 were 84.6%, 96.7%, and 99.0%, respectively. Percent reduction values for adults, DL4 and EL4 in the FBZ-FBZ and FBZ-OXF subgroups were 90.7%, 61.3%, 85.6% and 92.4%, 45.5%, and 73.0%, respectively. Variability in numbers of EL4 acquired during grazing by original controls and strategically treated cattle and variability in efficacy of August treatments was evident as observed in high outlier numbers of worms in all subgroups except the FBZ-CONT subgroup. Liveweights and gains were nearly identical in the two groups on 10 August.

Effect of chemoprophylaxis with avermectins on the immune response to gastrointestinal nematodes in first-season grazing calves

The influence of chemoprophylaxis on the immune response to gastrointestinal nematodes was evaluated in three groups of ten first-season grazing calves. Group C functioned as untreated controls, whereas Group L received two treatments, one at turn-out and one 8 weeks later, with doramectin (200 micrograms kg-1) and Group H three treatments, 3, 8, and 13 weeks post turn-out, with ivermectin (200 micrograms kg-1). At housing, five calves of each group were randomly selected for necropsied for worm counts. The remaining calves were challenged with 50,000 Ostertagi and 100,000 Cooperia oncophora and necropsied 4 weeks later. During the grazing season, Group C suffered from an outbreak of parasitic gastroenteritis which necessitated two anthelmintic treatments. In both treated groups no clinical symptoms were observed and growth rates were normal. Pepsinogen levels and antibody concentrations indicated a moderate and low gastrointestinal nematode infection in Group L and Group H, respectively. The Ostertagia and Cooperia worm populations present in the calves necropsied at housing were reduced in both treated groups in comparison with Group C. In the challenged calves, egg output was significantly higher in Group H than in Group L and Group C. Ostertagia and Cooperia worm burdens after challenge were high in Group H, moderate to low in Group L and low in Group C. This study indicates that highly suppressive prophylactic programmes, such as the ivermectin 3, 8 and 13 weeks schedule, can impair immune development against gastrointestinal nematodes during the first grazing season.

Control of gastrointestinal nematodes in first-season grazing calves by two strategic treatments with doramectin

Twenty first-season Holstein crossbred calves were used in a study conducted to investigate the efficacy of two strategic treatments with doramectin (s.c. 200 micrograms kg-1 bodyweight). They were allocated in two equal groups: Group D was treated with doramectin at turn-out and 8 weeks later and Group C served as control group. Tracers were used at turn-out, in August and before housing. At monthly intervals all principal animals were weighed, and their faeces were sampled for faecal egg counts and cultured for larval identification. Serum samples were collected for determination of pepsinogen. Animals were slaughtered for worm counts 3 weeks after housing. Clinical signs of parasitic gastroenteritis (PGE) in Group C necessitated a salvage treatment with pyrantel citrate. No signs of PGE were seen in Group D. The faecal egg output remained very low (less than 50 eggs g-1) in Group D, whereas in Group C a mean geometric maximum of 352 eggs g-1 was observed. Pepsinogen levels were below 2000 mU tyrosine in Group D, compared with maximum levels of 4190 mU tyrosine in Group C. The worm counts of the tracers at housing showed an overall reduction of 94% in the total number of gastrointestinal nematodes present on the D pasture, compared with the C pasture. Worm counts of the principal animals showed an 87.8% reduction in the total worm burden. The present results show clearly that doramectin given at turn-out and at Week 8 controls PGE in calves during the first grazing season.

Field evaluation of the efficacy of the fenbendazole slow-release bolus in the control of gastrointestinal nematodes of first-season grazing cattle

The ability of fenbendazole slow release bolus (Panacur SR Bolus, Hoechst) to control gastrointestinal parasitism in calves during their first grazing season at pasture was evaluated in two field trials. The infection level on both investigated farms was low and the control animals did not develop parasitic gastroenteritis. However, it was possible to demonstrate significant differences in the parasitological and biochemical parameters between the control and treated groups during the grazing season. Faecal egg counts and blood pepsinogen levels in the control cattle at both trials sites were significantly higher than those of the bolus-treated cattle.

Oxfendazole treatment of non-parasitized lambs and its effect on the immune system

Ten parasite-free lambs were drenched with oxfendazole on days 0 and 28 and, one day after each drench, were injected with human erythrocytes and ovalbumin. Ten other antigen-injected lambs were not drenched (controls). Lymphocytes collected 3 days after each antigen injection and cultured in RPMI 1640 plus 5% fetal calf serum (FCS) and lymphocytes collected 3 days after the first and 3 and 7 days after the second antigen injection and cultured in 50% autologous serum had decreased blastogenic activity compared with control lymphocytes. After the second drench, decreased blastogenesis was seen with lymphocytes collected on days 3 and 7 and cultured in 5% FCS and concanavalin A (Con A) and on day 3 when cultured in 5% FCS and phytohaemagglutinin (PHA). Decreased blastogenesis was also seen with lymphocytes collected 7 and 29 days after the second injection of antigen and cultured in 50% autologous serum plus Con A and on days 3, 7 and 29 when cultured in 50% autologous serum and PHA. Significantly depressed antibody responses to both antigens were seen after the second drench. The serum complement level was depressed 3 days after the second injection of antigen. Serum nitric oxide levels were significantly depressed 3 and 21 days after the first and 7 and 21 days after the second injection of antigen. There were no differences in levels of growth-promoting hormones but the drenched lambs gained significantly more weight than the controls.

Efficacy of doramectin in the prevention of gastrointestinal nematode infections in grazing cattle

Two studies were performed to investigate the efficacy of doramectin in the prevention of infection with Ostertagia ostertagi and Cooperia oncophora in grazing calves. In each study, 24 parasite-naive calves were randomly allotted to two equal groups and treated with either doramectin at 200 micrograms kg-1 or saline prior to mid-season turnout (Day 0) onto contaminated pasture. Faecal egg counts were carried out twice weekly from 15 to 64 days after turnout and the cumulative faecal egg count was calculated for each group of calves. In the doramectin-treated animals, eggs first appeared in the faeces 19 days and 22 days later than in controls for Studies 1 and 2, respectively. Mean cumulative faecal egg counts over the 64 days were reduced in the doramectin-treated groups by 71% and 87% for Studies 1 and 2, respectively (P < 0.01). The potential utility of injectable doramectin in the seasonal control of gastrointestinal nematode infestations in relation to these findings is discussed.

Seroepidemiological study on Dictyocaulus viviparus infections in first year grazing cattle in northern Germany

In Lower Saxony, 103 of 258 (39.9%) first year grazing cattle herds were found to be serologically positive for antibodies against Dictyocaulus viviparus. Risk of infection was higher for cattle herds with an early turnout and a long grazing period, i.e. more than 150 days. Herds that were observed by the farmers at least once a day were less frequently seropositive than other herds. The early observation of clinical signs enables farmers to treat the animals in time and to prevent the spread of the disease. Supplementary feeding and prior grazing or mowing the pastures for hay or silage significantly reduced the risk of infection. Diagnosis of dictyocaulosis was done almost exclusively by the farmers on the basis of clinical symptoms with an accuracy of less than 50%. Anthelmintics were administered mainly as salvage treatments and not according to a strategic control regimen.

Evaluation of pepsinogen, gastrin and antibody response in diagnosing ostertagiasis

Ostertagia ostertagi is widely distributed and is one of the most important parasites affecting young bovine livestock. There is, therefore, a substantial need for sensitive and specific parameters in support of diagnosis of ostertagiasis, especially for subclinical disease related to production losses. In this review, the value and application of pepsinogen, gastrin and antibody response as diagnostic tools are discussed. These three parameters are useful and comparable for confirming clinical disease in calves during their first grazing season. However, their value for detecting subclinical parasitism is questionable. Differences in the course of gastrin and pepsinogen late in the grazing season can be correlated with larval inhibition and the possibility of ostertagiasis Type II. Relatively few serological methods have been developed for the immunodiagnosis of Ostertagia and until now the indirect antibody-detecting enzyme-linked immunosorbent assay (ELISA) has been the method of choice. Antibody measuring methods have several disadvantages, most notably a lack of sensitivity and specificity, which limits their use in longitudinal epidemiological studies. Considering the necessity of cost effectiveness and ease of use, it is anticipated that additional work will result in the enhancement and quality of current immunodiagnostic methods.

Diagnostic value of gastrin for clinical bovine ostertagiosis

Gastrin values were evaluated in 130 parasite naive calves, in 61 first season grazing calves during six field trials and in 8 experimentally infected adult immune cows. The gastrin values were linked to pepsinogen levels and daily weight gain. Also the influence of an anthelmintic treatment on pepsinogen and gastrin values was assessed during a clinical outbreak of ostertagiosis in a group of first season grazing calves. Mean gastrin levels in parasite naive calves were 106 pg/ml. Results show that a group mean of 400 pg/ml gastrin in first season grazing calves indicates a reduced daily weight gain but with no obvious clinical signs. During clinical outbreaks mean gastrin levels frequently reached 1,000 pg/ml with a severe weight loss and a mean pepsinogen level of 5,000 mU tyr. The serum gastrin concentration was strongly reduced 4 days post treatment. No gastrin response was noted following an Ostertagia challenge in adult immune cows. The value of gastrin as a diagnostic aid for ostertagiosis is discussed in relation to pepsinogen, the adult worm burden, larval inhibition and the technique involved in assessing gastrin.

Gastrin and pepsinogen changes during an Ostertagia ostertagi challenge infection in calves

Daily changes in serum gastrin and pepsinogen concentration have been studied during two types of infection with Ostertagia ostertagi in calves. In a first experiment two calves were trickle infected (10 times 10,000 L3 Ostertagia) and two animals received a single infection of 100,000 L3 Ostertagia. Gastrin and pepsinogen changes are discussed in relation to adult wormburdens. The second experiment involved 8 calves and was designed to investigate pepsinogen and gastrin changes following a challenge infection in previously sensitized calves. The high dosed group was infected with 5,000 L3 O. ostertagi during 30 days, the low dosed group received 500 L3 O. ostertagi and group 3 served as uninfected control. At day 41 post infection all animals were treated with oxfendazole and on day 61 challenged with 100,000 L3 O. ostertagi. Only in the high dosed group a distinct pepsinogen and gastrin reaction was noticed. Both parameters dropped to almost preinfection levels after treatment. Two days post challenge a moderate rise (+/- 1,000 mU tyr) of the pepsinogen concentration was observed in the previously infected animals and gastrin showed a temporary slight increase in several animals 8 to 10 days post challenge. The effect of treatment and challenge infection is discussed in relation to gastrin and pepsinogen changes and immunity.

Effect of naturally occurring nematode infections in the first and second grazing season on the growth performance of second-year cattle

Antibody titres against Ostertagia spp., Cooperia spp. and Dictyocaulus viviparus as well as pepsinogen values, reflecting exposure to nematode infection, differed significantly among herds of second-year cattle on 87 farms. Faecal examinations revealed that gastrointestinal nematode infections were present in all herds. Similar results were found in yearling-herds on the same farms a year earlier. Liveweight of yearlings per herd deviated from -64.7 kg to +94.4 kg from an age-adjusted population mean after the second grazing season. This mean herd weight deviation was significantly related negatively to antibody titre against Ostertagia spp. (linear regression, P less than 0.05; segmented curvilinear regression, P less than 0.01) and to antibody titre against Cooperia spp. (segmented curvilinear regression, P less than 0.05), both measured in the second grazing season. Antibody titre against Ostertagia spp. measured in the first grazing season, when yearlings were calves, was significantly correlated positively to age-adjusted body weights at the end of the second grazing season. The results suggested that immunity built up during the first year had a positive effect on growth performance in the second year, but that on average the acquired immunity was insufficient to prevent reduced weight gains in the second grazing season.

Comparison of a levamisole sustained-release bolus and ivermectin treatment to prevent bovine lungworm infection

The efficacy of a levamisole sustained-release bolus to prevent parasitic bronchitis in calves in their first grazing season was compared to ivermectin treatment at three, eight and thirteen weeks after turn out. Contamination of the pasture was established by experimentally infected seeder calves. Twenty calves were split into two groups. Ten calves of one group received a bolus at the start of the experiment. In the other group the calves were treated with ivermectin at 21, 56 and 91 days. Two principal calves from each group were killed during the experiment to study histopathological changes. Pairs of tracer calves were introduced on both pastures at intervals of four weeks throughout the grazing period. The permanent calves were challenged with lungworm larvae at housing and slaughtered four weeks later. Both systems prevented parasitic bronchitis. Larval output was completely reduced in the ivermectin-treated calves while all bolus-treated calves excreted larvae at certain times. The highest group average was 4 larvae per gram faeces. Eosinophilia, ELISA-titres and histopathological changes confirmed the differences in larval uptake. Challenge infection was not successful in either group and no worms were found at slaughter. Weight gain was significantly different at housing in favour of the ivermectin-treated calves, but after challenge this was reduced due to a higher weight gain in the bolus-treated calves. The practical consequences of the results have been discussed.

Chemoprophylaxis and immunity to parasitic bronchitis in cattle--a field experiment comparing topical ivermectin and an oxfendazole intraruminal device

Seeder calves infected with Dictyocaulus viviparus were used to contaminate a field divided into three similar paddocks. Twenty-four autumn-born calves were allocated to three matched groups; one group was given topical ivermectin treatments (0.5 mg/kg) at 3, 8 and 13 weeks after turnout (Day 0); each member of a second group was given an oxfendazole pulse-release intraruminal device (OPRB) at turnout; while a third group was kept as untreated controls to monitor the natural epidemiological pattern of events. Severe pasteurella pneumonia exacerbated by lungworm infection occurred in the controls after Day 24. Two died and repeated doses of antibiotic and anthelmintic therapy were necessary to save the remainder. Clinical signs were much milder in the ivermectin and OPRB groups and resolved with only a single dose of antibiotic. The OPRB group excreted some lungworm larvae at this time, but none was detected in the faeces of the ivermectin group during the grazing season. At housing, five calves from each group and four lungworm-naive calves were challenged with D. viviparus larvae. The infection became patent in all challenge-control calves, but no larvae were passed by any of the trial animals. Post-mortem worm-counts revealed percentage takes for the challenge controls, trial controls, ivermectin and OPRB groups of 16.7, 0.01, 0.9 and 0.2, respectively. All trial groups had therefore developed a substantial immunity.

The influence of host immunity on the epidemiology of trichostrongyle infections in cattle

The acquisition of immunity to the important trichostrongyles of cattle is reviewed and the subsequent effect on the epidemiology of trichostrongylosis is discussed. Examples of factors which can delay or impair the development of immunity to these nematode infections are presented. These include the interactions with anthelmintic prophylactic programmes, nutrition, intercurrent infections, pregnancy and lactation.

Efficacy of early season anthelmintic treatment against gastrointestinal nematodes

The efficacy of levamisole and ivermectin in multiple-dose regimes for the control of parasitic gastroenteritis in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. Thirty-nine female Holstein crossbred calves were randomly divided into three groups. Paddock 1 was used for the controls, paddock 2 for the levamisole group (dosed at 3, 6 and 9 weeks after the start of grazing) and paddock 3 for the ivermectin group (dosed at 3 and 8 weeks after turn-out). The treatments were evaluated on the basis of live weight, faecal egg output, and serum pepsinogen levels. The impact of the therapeutic dosing at timed intervals during the first months of the grazing season was remarkable; egg output in the levamisole and ivermectin groups between June and early October was substantially lower. The treatments seem to adequately control Ostertagia, because serum pepsinogen values were much lower from August onwards. Better weight gains were observed in both the treatment groups. The experiment also illustrated the advantage of early housing of calves.

Field evaluation of an experimental albendazole pulse release bolus in the control of parasitic gastroenteritis in first-season grazing calves

A field experiment is described which evaluates the use of an experimental albendazole pulse release bolus (E-bolus) on gastrointestinal parasitism. The bolus was administered at turnout to 9 first-season grazing calves and 9 animals were kept as controls on separate pasture. Dry summer months accounted for low infection levels in the calves; no cases of parasitic gastroenteritis were observed. The E-bolus introduced at the start of the grazing season provided moderate control of gastrointestinal parasitism. The beneficial effect of the treatment was demonstrated by lower strongyle egg counts and significant differences in ELISA extinctions for Ostertagia, Cooperia and Dictyocaulus. However pepsinogen values were elevated in the bolus-treated group, probably because of the long interval (31 days) between the pulsed treatments. Although not significant there was a trend for the bolus-treated group to gain more weight than the controls.

Controlled release devices for the delivery of anthelmintics in cattle

Control of cattle helminths is not so much a problem of drug choice, but of drug delivery and livestock management. Several effective anthelmintics are available for domestic livestock, but their efficiency in limiting infection and disease attributed to important parasites such as Ostertagia and Haemonchus has been mainly due to good management practice and strategically timed treatment based on detailed epizootiological studies of parasite transmission. In most situations, treated animals remain fully susceptible to reinfection if continually grazed on contaminated pastures, and this is the rationale behind techniques for continuous or multiple treatment with anthelmintics. In response to these treatment requirements, the animal health industry has developed controlled release devices, or boluses, that can be implanted orally into the rumen (Fig. 1) to release anthelmintics over an extended period - either in a delayed or pulsed fashion. In this article, Gary Zimmerman and Eric Hoberg discuss same of the most promising of such devices.